"However, based on the serious nature of the review findings, the FDA requested and the manufacturer agreed to add a new contraindication to the sibutramine drug label," the Medwatch alert stated.
“然而，鉴于后果严重，FDA要求制造商在西布曲明的药品标签上加上新的禁忌症。”药品监督网如是说。
2
We do not use two kinds of secretory insulin, for example drugs like (unknown drug names) and also there is insulin plus (unknown drug name), but there is no contraindication to use this combination.